BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30944696)

  • 21. Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells.
    Jia T; Ming SX; Cao QQ; Xu FL
    Arch Oral Biol; 2020 Nov; 119():104905. PubMed ID: 32947166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
    Mouawad F; Gros A; Rysman B; Bal-Mahieu C; Bertheau C; Horn S; Sarrazin T; Lartigau E; Chevalier D; Bailly C; Lansiaux A; Meignan S
    Oral Oncol; 2014 Feb; 50(2):113-9. PubMed ID: 24290982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines.
    Schnoell J; Sparr C; Al-Gboore S; Haas M; Brkic FF; Kadletz-Wanke L; Heiduschka G; Jank BJ
    Invest New Drugs; 2023 Dec; 41(6):842-850. PubMed ID: 37934325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
    Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
    Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
    Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
    PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.
    Fan T; Pi H; Li M; Ren Z; He Z; Zhu F; Tian L; Tu M; Xie J; Liu M; Li Y; Tan M; Li G; Qing W; Reiter RJ; Yu Z; Wu H; Zhou Z
    J Pineal Res; 2018 Mar; 64(2):. PubMed ID: 29149494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma.
    Li M; Tang Q; Li S; Yang X; Zhang Y; Tang X; Huang P; Yin D
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23585. PubMed ID: 37986106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.
    Zhang Z; Zhou Z; Zhang M; Gross N; Gong L; Zhang S; Lei D; Zeng Q; Luo X; Li G; Li X
    Biomed Pharmacother; 2019 Oct; 118():109306. PubMed ID: 31545250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.
    Sung ES; Kim JY; Ahn YT; Lee IW; Choi SW; Jang HB; Lee JC; An WG
    Anticancer Res; 2020 Nov; 40(11):6295-6303. PubMed ID: 33109567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation.
    Zakki SA; Muhammad JS; Li JL; Sun L; Li ML; Feng QW; Li YL; Cui ZG; Inadera H
    Metallomics; 2020 Mar; 12(3):396-407. PubMed ID: 31959998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.
    Zakelj MN; Prevc A; Kranjc S; Cemazar M; Todorovic V; Savarin M; Scancar J; Kosjek T; Groselj B; Strojan P; Sersa G
    Oncol Rep; 2019 Mar; 41(3):1658-1668. PubMed ID: 30628709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin and verteporfin synergistically suppress the growth and stemness of head and neck squamous cell carcinoma through the regulation of mitochondrial dynamics.
    Shin YY; Seo Y; Oh SJ; Ahn JS; Song MH; Kang MJ; Oh JM; Lee D; Kim YH; Sung ES; Kim HS
    J Pineal Res; 2022 Jan; 72(1):e12779. PubMed ID: 34826168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
    Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
    Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin.
    Catalán M; Rodríguez C; Olmedo I; Carrasco-Rojas J; Rojas D; Molina-Berríos A; Díaz-Dosque M; Jara JA
    Adv Exp Med Biol; 2021; 1326():95-109. PubMed ID: 33368015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grape seed extract targets mitochondrial electron transport chain complex III and induces oxidative and metabolic stress leading to cytoprotective autophagy and apoptotic death in human head and neck cancer cells.
    Shrotriya S; Deep G; Lopert P; Patel M; Agarwal R; Agarwal C
    Mol Carcinog; 2015 Dec; 54(12):1734-47. PubMed ID: 25557495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
    Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
    Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.
    Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida LO
    Arch Oral Biol; 2022 Sep; 141():105468. PubMed ID: 35679799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mechanism of cisplatin resistance in head and neck squamous cell carcinoma involving extracellular vesicles and a copper transporter system.
    Ogawa T; Ono K; Ryumon S; Kawai H; Nakamura T; Umemori K; Yoshida K; Kanemoto H; Obata K; Yoshioka N; Okui T; Okamoto K; Nagatsuka H; Ibaragi S
    Head Neck; 2024 Mar; 46(3):636-650. PubMed ID: 38164660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.